Concepedia

Segundo Mariz

SM

Statistics

Publications

20

Citations

1.2K

H-Index

14

Active since

1957

Affiliations

Takeda (United Kingdom)(Current)

Federal Institute for Drugs and Medical Devices

European Medicines Agency

University of Lisbon

Baylor College of Medicine

Segundo Mariz is an author at Takeda (United Kingdom) specializing in medicine, clinical pharmacology, and diabetes mellitus.

Publications per year

1957–2023

20

Publications

20

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.

Irene L. Andrulis, Shelley B. Bull, Martin E. Blackstein et al. · Journal of Clinical Oncology · 1998 · 447 citations

Medicine, Oncology, Pathology +16

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

Colin Baigent, William G. Herrington, Josef Coresh et al. · Kidney International · 2017 · 147 citations · Full text

Medicine, Nephrology, Good Clinical Practice +7

Double-Blind Crossover Study of High-Dose Cetirizine in Cholinergic Urticaria

Torsten Zuberbier, C. Münzberger, U.‐F. Haustein et al. · Dermatology · 2009 · 128 citations

Medicine, Pharmacology, Pharmacotherapy +10

Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire

Jean Bousquet, Jacques Duchateau, J.C. Pignat et al. · Journal of Allergy and Clinical Immunology · 1996 · 108 citations · Full text

Life Sciences, Pharmacotherapy, Allergy +15

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

Medicine, Endocrinology, Diabetology +11

1–5 of 20